Gilead Sciences
GILD
#129
Rank
โ‚ฌ129.18 B
Marketcap
104,12ย โ‚ฌ
Share price
-1.14%
Change (1 day)
22.10%
Change (1 year)

Gilead Sciences (GILD) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ21.42 Billion

According to Gilead Sciences's latest financial reports the company's total debt is โ‚ฌ21.42 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Gilead Sciences - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ25.66 B13.56%
2023-12-31โ‚ฌ22.60 B-3.9%
2022-12-31โ‚ฌ23.52 B-0.22%
2021-12-31โ‚ฌ23.57 B-7.67%
2020-12-31โ‚ฌ25.53 B16.29%
2019-12-31โ‚ฌ21.95 B-8.08%
2018-12-31โ‚ฌ23.88 B-14.57%
2017-12-31โ‚ฌ27.95 B11.61%
2016-12-31โ‚ฌ25.04 B24.17%
2015-12-31โ‚ฌ20.17 B97.78%
2014-12-31โ‚ฌ10.19 B112.25%
2013-12-31โ‚ฌ4.80 B-22.71%
2012-12-31โ‚ฌ6.21 B6.14%
2011-12-31โ‚ฌ5.85 B123.58%
2010-12-31โ‚ฌ2.61 B200.68%
2009-12-31โ‚ฌ0.87 B4.99%
2008-12-31โ‚ฌ0.82 B-7.63%
2007-12-31โ‚ฌ0.89 B-15.95%
2006-12-31โ‚ฌ1.06 B320.93%
2005-12-31โ‚ฌ0.25 B82915.56%
2004-12-31โ‚ฌ0.3 M-99.89%
2003-12-31โ‚ฌ0.27 B-51.83%
2002-12-31โ‚ฌ0.56 B99.73%
2001-12-31โ‚ฌ0.28 B5.25%
2000-12-31โ‚ฌ0.27 B209.94%
1999-12-31โ‚ฌ87.42 M2.22%
1998-12-31โ‚ฌ85.53 M3071.88%
1997-12-31โ‚ฌ2.69 M-50.77%
1996-12-31โ‚ฌ5.47 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
โ‚ฌ46.88 B 118.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ1.57 B-92.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ59.04 B 175.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ2.21 B-89.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ5.66 B-73.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ52.26 B 143.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ39.33 B 83.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ36.50 B 70.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ35.53 B 65.89%๐Ÿ‡บ๐Ÿ‡ธ USA